A genetic deficiency of ASMase prevented Cu2+-induced hepatocyte apoptosis, while ASMase inhibition with desipramine in rats with a mutation in the Atp7b gene, a genetic model of Wilson’s disease, protects against Cu2+ -induced hepatocyte death and liver failure. This evidence concerns the gene SMPD1 and liver failure.